SpyGlass Pharma, Inc. (SGP)
Develops eye implants that deliver glaucoma medication during cataract surgery
$21.62+0.04%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-18.1%
The outlook
SGP is trading near the lower end of its 52-week range, with a neutral analyst score. The average price target sits roughly 108% above the current price, though analyst coverage appears mixed. The stock shows mixed momentum relative to its moving averages.
What’s behind the score
Price trendMixed vs its moving averages
52-week range30% of the way from its 52-week low to high
Price targetAvg target +108% vs current price
Analyst price target
~12-month · 5 analysts$45.00average target+108.1% vs now
Now $21.62
Low $37.00High $62.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$722.8M
52-wk high
$32.44
52-wk low
$17.06
50-day avg
$20.01
200-day avg
$23.12
Trailing P/E
—